3-tyr-octreotide has been researched along with yttrium in 1 studies
| Studies (3-tyr-octreotide) | Trials (3-tyr-octreotide) | Recent Studies (post-2010) (3-tyr-octreotide) | Studies (yttrium) | Trials (yttrium) | Recent Studies (post-2010) (yttrium) |
|---|---|---|---|---|---|
| 95 | 2 | 4 | 3,385 | 166 | 1,626 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bernard, BF; Breeman, WA; Capello, A; de Jong, M; Konijnenberg, MW; Krenning, EP | 1 |
1 other study(ies) available for 3-tyr-octreotide and yttrium
| Article | Year |
|---|---|
Tyr3-octreotide and Tyr3-octreotate radiolabeled with 177Lu or 90Y: peptide receptor radionuclide therapy results in vitro.
Topics: Animals; Cell Line, Tumor; Cell Survival; Dose-Response Relationship, Drug; Lutetium; Octreotide; Peptides, Cyclic; Radioisotopes; Rats; Receptors, Peptide; Yttrium | 2003 |